CN1209339C - 6,6-二烷氧基-5-羟基-3-氧代-己酸酯的制备方法 - Google Patents

6,6-二烷氧基-5-羟基-3-氧代-己酸酯的制备方法 Download PDF

Info

Publication number
CN1209339C
CN1209339C CNB998113530A CN99811353A CN1209339C CN 1209339 C CN1209339 C CN 1209339C CN B998113530 A CNB998113530 A CN B998113530A CN 99811353 A CN99811353 A CN 99811353A CN 1209339 C CN1209339 C CN 1209339C
Authority
CN
China
Prior art keywords
formula
alkyl ester
dialkoxy
acid alkyl
oxo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB998113530A
Other languages
English (en)
Other versions
CN1320112A (zh
Inventor
J·施勒尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lonza AG
Original Assignee
Lonza AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lonza AG filed Critical Lonza AG
Publication of CN1320112A publication Critical patent/CN1320112A/zh
Application granted granted Critical
Publication of CN1209339C publication Critical patent/CN1209339C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00Preparation of carboxylic acid esters
    • C07C67/30Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
    • C07C67/333Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton
    • C07C67/343Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

本发明涉及式I的6,6-二烷氧基-5-羟基-3-氧代-己酸酯的制备方法,其中使乙酰乙酸烷基酯双阴离子与醛反应。式I的6,6-二烷氧基-5-羟基-3-氧代-己酸酯是制备HMG-CoA-还原酶抑制剂的重要合成结构单元。

Description

6,6-二烷氧基-5-羟基-3-氧代-己酸酯的制备方法
本发明涉及一种用式I表示的6,6-二烷氧基-5-羟基-3-氧代-己酸酯的制备方法
式中R1和R2相同或不同,且为C1-6烷基。
上述的化合物是制备许多HMG-CoA还原酶抑制剂的重要合成结构单元(WO-A 92/10503)。
按照WO-A 92/10503,这些化合物通过乙酸酯与γ-二烷氧基-β-羟基酯的反应制得。然而,这种合成方法的缺点是难于获得后一种原料,因此是昂贵的。
本发明的目的是开发一种上述合成结构单元的更简单和更经济的制备方法。
这种目的可由权利要求1所述的方法来达到。
本发明方法包括式II的乙酰乙酸烷基酯
Figure C9981135300042
式中R1的定义同上,在碱的存在下与式III的醛反应,
Figure C9981135300043
式中R2的定义同上。
下文中,C1-6烷基理解为含有1-6个碳原子的直链或支链烷基,即甲基、乙基、异丙基、正丙基、正丁基、异丁基、叔丁基、戊基及其异构体、己基及其异构体。优选的是上述的C1-4烷基。
本发明方法的优点是式II的乙酰乙酸烷基酯是工业上可得到的。
式II的乙酰乙酸酯通过双烯酮与合适的醇反应制得。式II的乙酰乙酸酯也可由双烯酮现场制得。优选的式II乙酰乙酸酯是甲酯、乙酯、正丙酯、异丙酯、正丁酯、异丁酯和叔丁酯,特别优选的是叔丁酯。
式III的醛一般是市售的。优选的式III醛是1,1-二甲基缩乙二醛。
本发明的方法较好在基本上不含水的有机溶剂中进行。合适的溶剂是醚如四氢呋喃、二噁烷、乙醚、叔丁基·甲基醚等,芳族化合物如苯或甲苯,或烃如己烷以及上述溶剂的混合物。
反应温度一般选择在-80℃至130℃,较好为-40℃至20℃。
使用有助于形成式II的乙酰乙酸烷基酯双阴离子的碱。原则上,可直接用强碱(如丁基锂、甲基锂、苯基锂或氨基钠、二异丙基氨基锂或六甲基二硅氨烷基锂(lithium hexamethyldisilazane))形成双阴离子。
一般使用两步法,即先用较弱和廉价的碱使-CH2-基团脱质子,然后仅在第二步中用上述的强碱形成双阴离子。合适的较弱碱是金属氢化物,如碱金属氢化物或碱土金属氢化物,较好是氢化钠,但也可以是与乙酰乙酸酯形成烯胺(阴离子等当物)的仲胺(较好是吡咯烷)。在后一种情况下,双阴离子可理解为相应烯胺的阴离子。
所需的6,6-二烷氧基-5-羟基-3-氧代-己酸酯可用本领域中熟练技术人员熟知的方法制得,如通过中和反应混合物,然后用合适的溶剂进行萃取。
实施例
实施例1
6,6-二甲氧基-5-羟基-3-氧代-己酸叔丁酯的制备
0℃时,先将悬浮在50毫升四氢呋喃中的0.88克(22毫摩尔)氢化钠(55-60%矿物油悬浮液)加入一个250毫升圆底烧瓶中。然后用注射器将3.16克(20毫摩尔)乙酰乙酸叔丁酯加入到氢化钠的悬浮液,历时5-10分钟(冒出氢气)。继续搅拌5分钟后,向0℃的反应混合物中滴加13.1毫升正丁基锂溶液(1.6M己烷溶液),历时10分钟左右。继续搅拌1小时左右,然后向该反应混合物中滴加5.7克(22毫摩尔)1,1-二甲基缩乙二醛溶液,历时5分钟。0℃下继续搅拌3小时。0℃时,用5毫升浓盐酸猝灭反应(>pH8)。混合物用30水毫升稀释,用乙醚萃取二次,每次50毫升。浓缩有机相得到的粗产物用色谱柱提纯。这样分离得到所需的化合物,为稍有粘性的淡黄色油状物(产率为11%)。
1H NMR(400MHz,CDCl3):
                                       1.47(s,9H)
                                       2.73(dd,1H),
                                       2.75(宽单峰,1H),
                                       2.82(dd,1H),
                                       3.41(s,2H),
                                       3.44(s,3H),
                                       3.45(s,3H),
                                       4.13(m,1H),
                                       4.25(d,1H),
实施例2:
6,6-二甲氧基-5-羟基-3-氧代己酸叔丁酯的制备
0℃下先将悬浮于400毫升四氢呋喃中的6.6克(165毫摩尔)氢化钠(55-60%矿物油悬浮液)加入一个1000毫升有双层夹套的烧瓶中。然后用滴液漏斗向该氢化钠悬浮液中加入23.75克(150毫摩尔)乙酰乙酸叔丁酯,历时15分钟(有氢气冒出)。继续搅拌60分钟,然后在0℃下向该反应混合物中滴加100毫升正丁基锂溶液(1.6M己烷溶液,160毫摩尔),历时40分钟。继续搅拌25分钟左右,然后向该反应混合物中滴加34.7克(150毫摩尔)1,1-二甲基缩乙二醛(45%TBME溶液),历时30分钟。0℃下继续搅拌20分钟,20℃下搅拌1小时。0℃时,用37毫升浓盐酸和250毫升水猝灭反应(>pH8)。用乙醚萃取二次,每次250毫升。浓缩有机相得到的粗产物用色谱柱提纯。这样分离得到纯的所需化合物。
(产率:17.3克,44%)
实施例3
3-N-吡咯烷基-2-丁烯酸叔丁酯的制备
将乙酰乙酸叔丁酯(7.91克,50毫摩尔)的甲苯(50毫升)溶液与3.75克吡咯烷(52.5毫摩尔)混合,用水分离器回流1.5小时。这时已分离掉理论量的水。浓缩反应混合物后可得到烯胺。产率基本上为定量。
1H NMR(400MHz,CDCl3):
                                      1.46(s,9H)
                                      1.91(m,4H),
                                      2.43(s,3H),
                                      3.27(宽单峰,4H),
                                      4.41(s,1H).

Claims (8)

1.式I的6,6-二烷氧基-5-羟基-3-氧代-己酸酯的制备方法,
式中R1和R2是相同或不同的,且为C1-6烷基,其特征在于在碱的存在下式II的乙酰乙酸烷基酯
式中R1的定义同上,与式III的醛反应,
Figure C998113530002C3
式中R2的定义同上。
2.如权利要求1所述的方法,其特征在于所述的反应在基本上不含水的有机溶剂中进行。
3.如权利要求1或2所述的方法,其特征在于所述的反应在-80℃至130℃进行。
4.如权利要求1所述的方法,其特征在于使用能形成式II的乙酰乙酸烷基酯双阴离子的碱。
5.如权利要求4所述的方法,其特征在于先用金属氢化物在式II的乙酰乙酸烷基酯的-CH2-官能团上脱质子或通过形成烯胺来形成相应的阴离子等当物,然后马上用选自丁基锂、甲基锂、苯基锂、氨基钠、二异丙基氨基锂或六甲基二硅氨烷基锂的碱形成双阴离子。
6.如权利要求5所述的方法,其特征在于所述的金属氢化物是碱金属氢化物或碱土金属氢化物。
7.如权利要求5所述的方法,其特征在于所述的金属氢化物是氢化钠。
8.如权利要求5所述的方法,其特征在于用仲胺形成式II的乙酰乙酸烷基酯的烯胺。
CNB998113530A 1998-09-25 1999-09-23 6,6-二烷氧基-5-羟基-3-氧代-己酸酯的制备方法 Expired - Fee Related CN1209339C (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP98118191 1998-09-25
EP98118191.0 1998-09-25
US14704199P 1999-08-03 1999-08-03
US60/147,041 1999-08-03

Publications (2)

Publication Number Publication Date
CN1320112A CN1320112A (zh) 2001-10-31
CN1209339C true CN1209339C (zh) 2005-07-06

Family

ID=56289947

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB998113530A Expired - Fee Related CN1209339C (zh) 1998-09-25 1999-09-23 6,6-二烷氧基-5-羟基-3-氧代-己酸酯的制备方法

Country Status (11)

Country Link
EP (1) EP1115689B1 (zh)
JP (1) JP2002525345A (zh)
CN (1) CN1209339C (zh)
AT (1) ATE259774T1 (zh)
AU (1) AU6087299A (zh)
CA (1) CA2345134A1 (zh)
CZ (1) CZ20011044A3 (zh)
HU (1) HUP0103515A3 (zh)
PL (1) PL346899A1 (zh)
SK (1) SK4202001A3 (zh)
WO (1) WO2000018718A1 (zh)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2670206B1 (fr) * 1990-12-11 1993-01-22 Rhone Poulenc Sante Procede de preparation de derives de l'acide dihydroxy-3,5 pentanouique.

Also Published As

Publication number Publication date
ATE259774T1 (de) 2004-03-15
CN1320112A (zh) 2001-10-31
AU6087299A (en) 2000-04-17
JP2002525345A (ja) 2002-08-13
WO2000018718A1 (de) 2000-04-06
EP1115689A1 (de) 2001-07-18
PL346899A1 (en) 2002-03-11
CZ20011044A3 (cs) 2001-09-12
CA2345134A1 (en) 2000-04-06
SK4202001A3 (en) 2001-12-03
HUP0103515A2 (hu) 2003-08-28
EP1115689B1 (de) 2004-02-18
HUP0103515A3 (en) 2003-10-28

Similar Documents

Publication Publication Date Title
CZ20031946A3 (cs) Nový způsob syntézy atorvastinu a fenylboronátu jako meziproduktů
DE69612086T2 (de) Verfahren zur herstellung von (+)compactin und (+)mevinolin derivaten mit beta-hydroxy-delta-lactonresten
US10081613B2 (en) 2-(alkoxy or aryloxy carbonyl)-4-methyl-6-(2,6,6-trimethylcyclohex-1-enyl)hex-2-enoic acid compounds, its preparation and use
US4808725A (en) Process for the preparation of the (-)-antipode of (E)-1-cyclohexyl-4, 4-dimethyl-3-hydroxy-2-(1,2,4-triazol-1-yl)-pent-1-ene
CN1209339C (zh) 6,6-二烷氧基-5-羟基-3-氧代-己酸酯的制备方法
KR100881617B1 (ko) 아토바스타틴 제조를 위한 중간체 및 그의 제조방법
EP0098620B1 (en) Alpha,beta-dihydropolyprenyl derivatives and a process for preparing these derivatives
CN1173983C (zh) 制备鏻盐的方法
EP1213279B1 (en) Venlafaxine production process
Solladié-Cavallo et al. Diastereoselective reduction of an α-keto-ester derived from (−)-8-phenylmenthol: A 4-step synthesis of R-Halostachine analogue.
KR100208312B1 (ko) 2,4- 디히드록시아디프산 유도체
EP1125918A1 (en) Tricyclodecanyl esters and their preparation
US6486345B1 (en) Method for producing 6,6-dialkoxy-5-hydroxy-3-oxo-hexanoic acid esters
Carlsson et al. Enamine chemistry—XXV: Reduction of enaminones by LiAlH4 and NaBH4. Synthesis of α, β-unsaturated aldehydes
JP4252037B2 (ja) 5−ヒドロキシ−3−オキソ−ヘキサン酸誘導体の新規な製造方法
Kashima et al. Asymmetric borane reduction of ketones promoted by menthopyrazole‐zncl2 complex
JP3867213B2 (ja) ケトアルデヒドの製造方法
CN1056843C (zh) 制备脱水芽子碱酯的方法
HU187822B (en) Process for producing tetra-substituted cyclopropane derivatives
EP0647640B1 (en) Process for the preparation of pilocarpine derivatives
EP1373241B1 (de) Verfahren zur herstellung optisch aktiver dihydropyrone
US20010053862A1 (en) Process for preparing arylpiperidine carbinol intermediates and derivatives
US6313353B1 (en) Method for producing an optically active acyloin
EP1614682A1 (en) Process for producing quinoline compound
US20020035276A1 (en) Method for producing chroman-carboxylic acid

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee